Cargando…

The epigenetic landscape of clear-cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) is the most common subtype of all kidney tumors. During the last few years, epigenetics has emerged as an important mechanism in ccRCC pathogenesis. Recent reports, involving large-scale methylation and sequencing analyses, have identified genes frequently ina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kluzek, Katarzyna, Bluyssen, Hans A, Wesoly, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Codon Publications 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345536/ https://www.ncbi.nlm.nih.gov/pubmed/28326264 http://dx.doi.org/10.15586/jkcvhl.2015.33

Ejemplares similares

Potential Approaches and Recent Advances in Biomarker Discovery in Clear-Cell Renal Cell Carcinoma
por: Majer, Weronika, et al.
Publicado: (2015)

FUT11 as a potential biomarker of clear cell renal cell carcinoma progression based on meta-analysis of gene expression data
por: Zodro, Elżbieta, et al.
Publicado: (2013)

Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates
por: Pstrąg, Natalia, et al.
Publicado: (2018)

Identification of RCC Subtype-Specific microRNAs–Meta-Analysis of High-Throughput RCC Tumor microRNA Expression Data
por: Kajdasz, Arkadiusz, et al.
Publicado: (2021)

Time-dependent recruitment of GAF, ISGF3 and IRF1 complexes shapes IFNα and IFNγ-activated transcriptional responses and explains mechanistic and functional overlap
por: Sekrecka, Agata, et al.
Publicado: (2023)

The renal clear cell carcinoma immune landscape
por: Saad, Omar A., et al.
Publicado: (2022)

Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma
por: Kim, Myung-Chul, et al.
Publicado: (2021)

A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses
por: Michalska, Agata, et al.
Publicado: (2018)

The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments
por: Angulo, Javier C., et al.
Publicado: (2021)

Data Mining of Atherosclerotic Plaque Transcriptomes Predicts STAT1-Dependent Inflammatory Signal Integration in Vascular Disease
por: Sikorski, Krzysztof, et al.
Publicado: (2014)

Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
por: Eskandarian Boroujeni, Mahdi, et al.
Publicado: (2022)

Genetic and Epigenetic Characteristics in Isolated Pancreatic Metastases of Clear-Cell Renal Cell Carcinoma
por: Sellner, Franz, et al.
Publicado: (2023)

Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature
por: John, Alexius, et al.
Publicado: (2023)

Identification of STAT1 and STAT3 Specific Inhibitors Using Comparative Virtual Screening and Docking Validation
por: Szelag, Malgorzata, et al.
Publicado: (2015)

Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease
por: Szelag, Malgorzata, et al.
Publicado: (2016)

Immune Infiltration Landscape in Clear Cell Renal Cell Carcinoma Implications
por: Wang, Yongfeng, et al.
Publicado: (2021)

Identification of epigenetic dysregulation gene markers and immune landscape in kidney renal clear cell carcinoma by comprehensive genomic analysis
por: Xie, Linli, et al.
Publicado: (2022)

SINBAD, structural, experimental and clinical characterization of STAT inhibitors and their potential applications
por: Plens-Gałąska, Martyna, et al.
Publicado: (2022)

Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients
por: Huang, Jiwei, et al.
Publicado: (2021)

STAT1 as a central mediator of IFNγ and TLR4 signal integration in vascular dysfunction
por: Sikorski, Krzysztof, et al.
Publicado: (2012)

Landscape of immune cell infiltration in clear cell renal cell carcinoma to aid immunotherapy
por: Bai, Dan, et al.
Publicado: (2021)

Epigenetic signature predicts overall survival clear cell renal cell carcinoma
por: Wang, Yejinpeng, et al.
Publicado: (2020)

Current Landscape and the Potential Role of Hypoxia-Inducible Factors and Selenium in Clear Cell Renal Cell Carcinoma Treatment
por: Garje, Rohan, et al.
Publicado: (2018)

Expression and epigenetic regulatory mechanism of BNIP3 in clear cell renal cell carcinoma
por: Shao, Yanxiang, et al.
Publicado: (2018)

The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy
por: van der Mijn, Johannes C., et al.
Publicado: (2022)

Antigenic targets in clear cell renal cell carcinoma
por: Schindler, Nicholas R., et al.
Publicado: (2023)

The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma
por: Zhai, Xinyu, et al.
Publicado: (2023)

Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
por: Xu, Kevin Y, et al.
Publicado: (2015)

Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma
por: Yu, Mengxue, et al.
Publicado: (2023)

Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA
por: Kluzek, Katarzyna, et al.
Publicado: (2017)

Head and Neck Squamous Cell Carcinoma: Epigenetic Landscape
por: Romanowska, Kamila, et al.
Publicado: (2020)

Heart Metastases of Clear Cell Renal Cell Carcinoma
por: Romejko, Katarzyna, et al.
Publicado: (2023)

Emerging Targets in Clear Cell Renal Cell Carcinoma
por: Chen, Yu-Wei, et al.
Publicado: (2022)

Novel landscape of HLA‐G isoforms expressed in clear cell renal cell carcinoma patients
por: Tronik‐Le Roux, Diana, et al.
Publicado: (2017)

Identification of anoikis-related subtypes and immune landscape in kidney renal clear cell carcinoma
por: Ding, Wencong, et al.
Publicado: (2023)

Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinoma
por: de Velasco, Guillermo, et al.
Publicado: (2018)

Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma
por: Neely, Benjamin A., et al.
Publicado: (2016)

First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape
por: Gulati, Shuchi, et al.
Publicado: (2022)

Clearing up Clear Cell: Clarifying the Immuno-Oncology Treatment Landscape for Metastatic Clear Cell RCC
por: Doppalapudi, Sai Krishnaraya, et al.
Publicado: (2021)

Epigenetic Alterations of Chromosome 3 Revealed by NotI-Microarrays in Clear Cell Renal Cell Carcinoma
por: Dmitriev, Alexey A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qdsnqt6433f4ednt6cthvqfmjj